At what pace is the empty intravenous (iv) bags market growing, and what is its estimated value?
The empty intravenous (IV) bags market size has grown rapidly in recent years. It will grow from $6.36 billion in 2024 to $7.2 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to the increased prevalence of chronic diseases, high demand for intravenous therapies, growth in the aging population, improvements in healthcare infrastructure, and expansion of hospital and clinical services.
The empty intravenous (IV) bags market size is expected to see rapid growth in the next few years. It will grow to $11.75 billion in 2029 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to the growing home healthcare market, increasing incidence of malnutrition, rising demand for personalized medicine, expansion of healthcare services in emerging markets, and increasing surgical procedures. Major trends in the forecast period include smart IV bags with sensors, biodegradable IV bags, improved sterility and contamination prevention, advanced manufacturing techniques, and integration with electronic health records (EHR).
Get Your Free Sample of The Global Empty Intravenous (IV) Bags Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15800&type=smp
Which Market drivers have played a significant role in driving the empty intravenous (iv) bags market?
The rising number of surgical procedures is expected to propel the growth of the empty intravenous (IV) bag market going forward. Surgical procedures are medical interventions or treatments that involve invasive techniques to address or correct health conditions, injuries, or abnormalities within the body. Surgical procedures are increasing due to advancements in medical technology, an aging population, the prevalence of chronic diseases, improved access to healthcare, and patient demand and expectations. Empty intravenous (IV) bags play a critical role in providing essential fluids, medications, blood products, and anesthesia support during surgical procedures. For instance, in February 2024, according to the National Healthcare Statistics, a US-based government agency, in 2022 cataract surgery was the most common surgical procedure, totaling 39,347 cases, with 98.3% performed as day cases. This was followed by 20,537 caesarean sections and 12,830 hip replacements, nearly all of which were inpatient procedures. Therefore, the rising number of surgical procedures is driving the growth of the empty intravenous (IV) bag market.
What are the key segments within the empty intravenous (iv) bags market?
The empty intravenous (IV) bags market covered in this report is segmented –
1) By Product: Polyvinyl Chloride, Non-Polyvinyl Chloride
2) By Type: Single Chamber, Multi-Chamber
3) By Material: Polypropylene, Polyester Ether, Ethylene Vinyl Acetate (EVA), Other Materials
4) By Capacity: 50 ML – 100 ML, 100 ML – 250 ML, 250 ML – 500 ML, Above 500 ML
5) By Application: Hospital, Clinic, Other Applications
Subsegments:
1) By Polyvinyl Chloride (PVC): Flexible PVC IV Bags, Rigid PVC IV Bags
2) By Non-Polyvinyl Chloride (Non-PVC): Ethylene Vinyl Acetate (EVA) IV Bags, Other Non-PVC Materials
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/empty-intravenous-iv-bags-global-market-report
Which key players are shaping the empty intravenous (iv) bags market?
Major companies operating in the empty intravenous (IV) bags market are Pfizer Inc., Fresenius Medical Care AG KGaA, Becton Dickinson and Company, Amcor LLC, Baxter International Inc., Grifols S.A., Hospira Inc., Nipro Corporation, B. Braun Medical Inc., ICU Medical Inc., RENOLIT Healthcare, Kiefel GmbH, Medisca Inc., Bioteque Corporation, BAUSCH Advanced Technology Group, Jorgensen Laboratories LLC, Technoflex, Sippex IV bags, AdvaCare Pharma Limited, Tacy Medical Inc., Polycine GmbH, JW Life Science Corp, Mitra Industries Private Limited
Which transformative trends will shape the empty intravenous (iv) bags market landscape?
Major companies operating in the Empty intravenous (IV) bags market are focused on advancing intravenous (IV) bags recycling by developing sustainable collection, processing, and repurposing methods to reduce environmental impact and promote circular economy practices within the healthcare sector. Advancing intravenous (IV) bags recycling” refers to the development and enhancement of processes and systems for recycling used IV bags, which are commonly made from plastic materials like polyvinyl chloride (PVC) or other recyclable polymers. For instance, in December 2023, Baxter International Inc., a US-based company that offers healthcare services launch of the first intravenous (IV) bag recycling pilot program in the United States, in collaboration with Northwestern Medicine. This initiative aims to address the environmental impact of single-use plastic IV bags, which are commonly disposed of in landfills after use..
How do regional factors impact the empty intravenous (iv) bags market, and which region is the largest contributor?
North America was the largest region in the empty intravenous (IV) bags market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the empty intravenous (IV) bags market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Empty Intravenous (IV) Bags Market Report 2025 Offer?
The empty intravenous (iv) bags market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Empty intravenous (IV) bags are sterile, flexible containers designed for the administration of fluids, medications, or nutrients directly into a patient’s bloodstream. These bags are used in medical settings to prepare and deliver IV solutions. The bags come in various sizes and materials, typically equipped with ports for easy connection to IV lines and infusion sets.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15800
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
